Майкл Поллан - Мир иной. Что психоделика может рассказать о сознании, смерти, страстях, депрессии и трансцендентности

Любой долговременный проект, особенно написание книги, неизбежно влияет на эмоциональную погоду в семье, а уж такой, как этот, и подавно. Айзек, для меня было очень важно иметь возможность говорить с тобой во время моих путешествий; из наших с тобой разговоров я всегда выношу что-то умное, полезное и неожиданное. Твои поддержка, любопытство и ободрение решают всё.

Когда я отправился в это долгое и необычное путешествие, Джудит сразу же задалась вопросом, чем эта затея обернется для нашего более чем тридцатилетнего партнерского сотрудничества. Вернусь ли я из него обновленным или хотя бы чуть изменившимся? Никогда не думал, что после стольких лет, проведенных вместе, что-то может сблизить нас еще больше, но именно это и произошло. Спасибо тебе, Джудит, за то, что подвигла меня испробовать что-то новое; спасибо за побуждавшие к поиску вопросы и сопровождавшие их озарения; спасибо за то, что внимательно читала и редактировала каждую главу, а больше всего за то, что была вместе со мной на всем этом долгом пути.

Bai, Yang, Laura A. Maruskin, Serena Chen, Amie M. Gordon, Jennifer E. Stellar, Galen D. McNeil, Kaiping Peng, and Dacher Keltner. “Awe, the Diminished Self, and Collective Engagement: Universals and Cultural Variations in the Small Self.” Journal of Personality and Social Psychology 113, no. 2 (2017): 185–209. doi:10.1037/pspa0000087.

Barrett, Frederick S., Hollis Robbins, David Smooke, Jenine L. Brown, and Roland R. Griffiths. “Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences During Psychedelic Therapy Sessions.” Frontiers in Physiology 8 (July 2017): 1–12. doi: 10.3389 / fpsyg.2017.01238.

Beacon Health Options. “We Need to Talk About Suicide.” 2017.

Belser, Alexander B., Gabrielle Agin-Liebes, T. Cody Swift, Sara Terrana, Nesёe Devenot, Harris L. Friedman, Jeffrey Guss, Anthony Bossis, and Stephen Ross. “Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis.” Journal of Humanistic Psychology 57, no. 4 (2017): 354–88. doi:10.1177/0022167817706884.

Bogenschutz, Michael P., Alyssa A. Forcehimes, Jessica A. Pommy, Claire E. Wilcox, P. C.

R. Barbosa, and Rick J. Strassman. “Psilocybin-Assisted Treatment for Alcohol Dependence: A Proof-of-Concept Study.” Journal of Psychopharmacology 29, no. 3 (2015):289–99. doi:10.1177/0269881114565144.

Brewer, Judson. The Craving Mind: From Cigarettes to Smartphones to Love – Why We Get Hooked and How We Can Break Bad Habits. New Haven, Conn.: Yale University Press, 2017.

Buckner, Randy L., Jessica R. Andrews-Hanna, and Daniel L. Schacter. “The Brain’s Default Network: Anatomy, Function, and Relevance to Disease.” Annals of the New York Academy of Sciences 1124, no. 1 (2008): 1–38. doi:10.1196/annals.1440.011.

Carbonaro, Theresa M., Matthew P. Bradstreet, Frederick S. Barrett, Katherine A. MacLean, Robert Jesse, Matthew W. Johnson, and Roland R. Griffiths. “Survey Study of Challenging Experiences After Ingesting Psilocybin Mushrooms: Acute and Enduring Positive and Negative Consequences.” Journal of Psychopharmacology 30, no. 12 (2016): 1268–78.

Carhart-Harris, Robin L., et al. “Neural Correlates of the Psychedelic State as Determined by fMRI Studies with Psilocybin.” Proceedings of the National Academy of Sciences of the United States of America 109, no. 6 (2012): 2138–43. doi:10.1073/pnas.1119598109.

Carhart-Harris, Robin L., et al. “Psilocybin with Psychological Support for Treatment-Resistant Depression: An Open-Label Feasibility Study.” Lancet Psychiatry 3, no. 7 (2016): 619–27. doi:10.1016/S2215-0366(16)30065-7.

Carhart-Harris, Robin L., Mendel Kaelen, and David J. Nutt. “How Do Hallucinogens Work on the Brain?” Psychologist 27, no. 9 (2014): 662–65.

Carhart-Harris, Robin L., Robert Leech, Peter J. Hellyer, Murray Shanahan, Amanda Feilding, Enzo Tagliazucchi, Dante R. Chialvo, and David Nutt. “The Entropic Brain: A Theory of Conscious States Informed by Neuroimaging Research with Psychedelic Drugs.” Frontiers in Human Neuroscience 8 (Feb. 2014): 20. doi:10.3389/fnhum.2014.00020.

Cohen, Maimon M., Kurt Hirschhorn, and William A. Frosch. “In Vivo and In Vitro Chromosomal Damage Induced by LSD-25.” New England Journal of Medicine 277, no. 20 (1967): 1043–49. doi:10.1056/NEJM197107222850421.

Cohen, Sidney. The Beyond Within: The LSD Story . New York: Atheneum, 1964.

Cohen, Sidney. “A Classification of LSD Complications.” Psychosomatics 7, no. 3 (1966): 182–86.

Cohen, Sidney. “LSD and the Anguish of Dying.” Harper’s Magazine, Sept. 1965, 69–78.

Cohen, Sidney. “Lysergic Acid Diethylamide: Side Effects and Complications.” Journal of Nervous and Mental Disease 130, no. 1 (1960): 30–40.

Cohen, Sidney, and Keith S. Ditman. “Complications Associated with Lysergic Acid Diethylamide (LSD-25).” Journal of the American Medical Association 181, no. 2 (1962):161–62.

Cohen, Sidney, and Keith S. Ditman. “Prolonged Adverse Reactions to Lysergic Acid Diethylamide.” Archives of General Psychiatry 8, no. 5 (1963): 475–80.

Cole, Jonathan O., and Martin M. Katz. “The Psychotomimetic Drugs: An Overview.” Journal of the American Medical Association 187, no. 10 (1964): 758–61.

Davis, Wade. One River: Explorations and Discoveries in the Amazon Rain Forest . New York: Simon & Schuster, 1996.

Doblin, Rick. “Dr. Leary’s Concord Prison Experiment: A 34-Year Follow-Up Study.” Journal of Psychoactive Drugs 30, no. 4 (1998): 419–26. doi:10.1080/02791072.1998.10399715.

Doblin, Rick. “Pahnke’s ‘Good Friday Experiment’: A Long-Term Follow-Up and Methodological Critique.” Journal of Transpersonal Psychology 23, no. 1 (1991): 1–28. doi:10.1177/0269881108094300.

Dyck, Erika. Psychedelic Psychiatry: LSD from Clinic to Campus . Baltimore: Johns Hopkins University Press, 2008.

Dyer, Adrian G., Jair E. Garcia, Mani Shrestha, and Klaus Lunau. “Seeing in Colour: A Hundred Years of Studies on Bee Vision Since the Work of the Nobel Laureate Karl von Frisch.” Proceedings of the Royal Society of Victoria 127 (July 2015): 66–72. doi:10.1071/RS15006.

Eisner, Betty Grover. “Remembrances of LSD Therapy Past.” 2002. http://www.maps.org/images/pdf/books/remembrances.pdf.

Emerson, Ralph Waldo. Nature . Boston: James Munroe, 1836.

Epstein, Mark. Thoughts Without a Thinker: Psychotherapy from a Buddhist Perspective . New York: Basic Books, 1995.

Estrada, Alvaro. María Sabina: Her Life and Chants . Santa Barbara, Calif.: Ross-Erikson, 1981.

Fadiman, James. The Psychedelic Explorer’s Guide: Safe, Therapeutic and Sacred Journeys. Rochester, Vt.: Park Street Press, 2011.

Fahey, Todd Brendan. “The Original Captain Trips.” High Times, Nov. 1991.

Frank, Adam. “Minding Matter.” Aeon, March 2017.

Freud, Sigmund. Civilization and Its Discontents . New York: Norton, 1961.

Goldsmith, Neal. “A Conversation with George Greer and Myron Stolaroff.” 2013. https://erowid.org/culture/characters/stolaroff_myron/stolaroff_myron_interview1.shtml.

Gonzales v. O Centro Espirita Beneficente Uniao do Vegetal, 546 U.S. 418 (2006).

Gopnik, Alison. The Philosophical Baby: What Children’s Minds Tell Us About Truth, Love, and the Meaning of Life . New York: Farrar, Straus and Giroux, 2009.

Greenfield, Robert. Timothy Leary: A Biography . Orlando, Fla.: Harcourt, 2006.

Griffiths, R. R., W. A. Richards, U. McCann, and R. Jesse. “Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance.” Psychopharmacology 187, no. 3 (2006): 268–83. doi:10.1007/s00213-006-0457-5.

Grinker, Roy R. “Bootlegged Ecstasy.” Journal of the American Medical Association 187, no. 10 (1964): 768.

Grinker, Roy R. “Lysergic Acid Diethylamide.” Archives of General Psychiatry 8, no. 5 (1963): 425. doi:10.1056/NEJM196802222780806.

Grinspoon, Lester, and James B. Bakalar. Psychedelic Drugs Reconsidered . New York: Basic Books, 1979.

Grob, Charles S. “Psychiatric Research with Hallucinogens: What Have We Learned?” Yearbook for Ethnomedicine and the Study of Consciousness, no. 3 (1994): 91–112.

Grob, Charles S., Anthony P. Bossis, and Roland R. Griffiths. “Use of the Classic Hallucinogen Psilocybin for Treatment of Existential Distress Associated with Cancer.” In Psychological Aspects of Cancer: A Guide to Emotional and Psychological Consequences of Cancer, Their Causes and Their Management, edited by Brian I. Carr and Jennifer Steel, 291–308. New York: Springer, 2013. doi:10.1007/978-1-4614-4866-2.

Grob, Charles S., Alicia L. Danforth, Gurpreet S. Chopra, Marycie Hagerty, Charles R. McKay, Adam L. Halberstadt, and George R. Greer. “Pilot Study of Psilocybin Treatment for Anxiety in Patients with Advanced-Stage Cancer.” Archives of General Psychiatry 68, no. 1 (2011): 71–8. doi:10.1001/archgenpsychiatry.2010.116.

Grof, Stanislav. LSD: Doorway to the Numinous: The Groundbreaking Psychedelic Research into Realms of the Human Unconscious . Rochester, Vt.: Park Street Press, 2009.

Hertzberg, Hendrik. “Moon Shots (3 of 3): Lunar Epiphanies.” New Yorker, Aug. 2008.

Hoffman, Jan. “A Dose of a Hallucinogen from a ‘Magic Mushroom,’ and Then Lasting Peace.” New York Times, Dec. 1, 2016.

Hofmann, Albert. LSD, My Problem Child . Santa Cruz, Calif.: Multidisciplinary Association for Psychedelic Studies, 2009.

Huxley, Aldous. The Doors of Perception, and Heaven and Hell . New York: Harper & Row, 1963.

Huxley, Aldous. Moksha: Writings on Psychedelics and the Visionary Experience (1931–1963) . Edited by Michael Horowitz and Cynthia Palmer. New York: Stonehill, 1977.

Huxley, Aldous. The Perennial Philosophy . London: Chatto & Windus, 1947. doi:10.1017/S0031819100023330.

Isaacson, Walter. Steve Jobs . New York: Simon & Schuster, 2011.

James, William. The Varieties of Religious Experience . EBook. Project Gutenberg, 2014.

Johansen, Pеl-Шrjan, and Teri Suzanne Krebs. “Psychedelics Not Linked to Mental Health Problems or Suicidal Behavior: A Population Study.” Journal of Psychopharmacology 29, no. 3 (2015): 270–79. doi:10.1177/0269881114568039.

Johnson, Matthew W., Albert Garcia-Romeu, Mary P. Cosimano, and Roland R. Griffiths. “Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction.” Journal of Psychopharmacology 28, no. 11 (2014): 983–92. doi:10.1177/0269881114548296.